Is Vestibular Schwannoma hereditary?

Most cases of Vestibular Schwannoma are sporadic (non-hereditary) and occur spontaneously in individuals without a family history. However, when Vestibular Schwannoma occurs as part of Neurofibromatosis Type 2 (NF2), it is an inherited condition caused by a germline mutation in the NF2 gene, which follows an autosomal dominant inheritance pattern.

Is Vestibular Schwannoma a hereditary condition?

It is crucial to distinguish between sporadic and hereditary forms of Vestibular Schwannoma. The vast majority of people diagnosed with this condition—often called an acoustic neuroma—have a sporadic tumor, meaning it is not inherited and will not be passed down to their children. In these cases, the tumor arises from a somatic mutation that occurs only in the cells of the tumor itself. Conversely, if Vestibular Schwannoma is associated with Neurofibromatosis Type 2 (NF2), the underlying genetic mutation is present in every cell of the body and can be passed through families.

What is the inheritance pattern for NF2-related Vestibular Schwannoma?

When Vestibular Schwannoma is a manifestation of NF2, it follows an autosomal dominant inheritance pattern. This means that if a parent carries the NF2 gene mutation, each child has a 50% chance of inheriting the mutation. It is important to note that even within families, the severity of the disease and the age of onset for Vestibular Schwannoma can vary significantly due to factors like variable expressivity.

Are de novo mutations common in this disease?

Yes, de novo (new) mutations are quite common in the context of hereditary Vestibular Schwannoma. Approximately 50% of individuals diagnosed with NF2 are the first person in their family to have the condition, meaning the mutation occurred spontaneously in the egg or sperm or very early in embryonic development. For these individuals, their parents do not carry the mutation, and the risk to siblings is generally low, though the risk to the individual's future children remains 50%.

When is genetic testing and counseling recommended?

Genetic testing is typically not indicated for individuals with a solitary, unilateral Vestibular Schwannoma who have no family history of NF2 or other related symptoms. However, testing and counseling are strongly recommended in the following scenarios:

• Bilateral Vestibular Schwannoma (tumors on both hearing nerves), which is a hallmark of NF2.


• A personal or family history of other tumors associated with NF2, such as meningiomas, schwannomas, or ependymomas.


• Individuals with a known family history of NF2 who wish to explore reproductive options.


• Patients diagnosed with Vestibular Schwannoma at a very young age (e.g., under 20 years old).

What are the implications for family planning?

For families with a confirmed NF2 mutation, genetic counseling is an essential step before pregnancy. Clinical geneticists can discuss options such as Preimplantation Genetic Testing (PGT) alongside In Vitro Fertilization (IVF), which allows for the screening of embryos to identify those that have not inherited the NF2 mutation. With over 525 community members on DiseaseMaps.org, many have navigated these complex paths and found support in sharing their experiences with others facing similar genetic questions.

Next steps

• Consult with a board-certified clinical geneticist to review your family medical history.


• If you have bilateral tumors, request a referral to a neuro-oncology center specializing in phakomatoses or NF2.


• Join the DiseaseMaps.org community to connect with others who have navigated the diagnosis of Vestibular Schwannoma.


• Keep a detailed record of your family history, including any relatives with hearing loss, early-onset tumors, or skin lesions.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Vestibular Schwannoma.


• Orphanet: Neurofibromatosis type 2.


• OMIM (Online Mendelian Inheritance in Man): Neurofibromatosis, Type 2.


• Children's Tumor Foundation: NF2-Related Schwannomatosis resources.